Working… Menu

Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00044031
Recruitment Status : Completed
First Posted : August 20, 2002
Last Update Posted : April 17, 2014
Information provided by (Responsible Party):
Cancer Advances Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2004
Actual Study Completion Date : October 2007